Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Beth A. Overmoyer
Phase II and Biomarker Study of Cabozantinib in Metastatic Triple‐Negative Breast Cancer Patients
Oncologist
Cancer Research
Medicine
Oncology
Related publications
Phase II Study of Pembrolizumab and Capecitabine for Triple Negative and Hormone Receptor-Positive, HER2−negative Endocrine-Refractory Metastatic Breast Cancer
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Feasibility Study of Personalized Peptide Vaccination for Metastatic Recurrent Triple-Negative Breast Cancer Patients
Breast Cancer Research
Cancer Research
Oncology
Biology, Metastatic Patterns, and Treatment of Patients With Triple-Negative Breast Cancer
Clinical Cancer Reviews
Phase II Study of Carboplatin, Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer
The Internet Journal of Oncology
A Phase 2 and Biomarker Study of Cabozantinib in Patients With Advanced Cholangiocarcinoma
Cancer
Cancer Research
Oncology
Immediate and Long-Term Outcomes of Drug Treatment in Patients With Metastatic Triple Negative Breast Cancer
Malignant tumours
PIM-1 Kinase: A Potential Biomarker of Triple-Negative Breast Cancer
OncoTargets and Therapy
Oncology
Pharmacology
The Results of a Study of Chemotherapy With Bevacizumab, Oxaliplatin and Paclitaxel in Patients With Metastatic Triple Negative Breast Cancer
Malignant tumours
Nab-Paclitaxel for the Management of Triple-Negative Metastatic Breast Cancer
Anti-Cancer Drugs
Cancer Research
Oncology
Pharmacology
